Navigation Links
Millennium Laboratories Announces New General Counsel Martin Price and Chief Compliance Officer Janna Sipes
Date:6/13/2011

SAN DIEGO, June 13, 2011 /PRNewswire/ -- Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today the hiring of Martin Price as General Counsel and Janna Sipes as Senior Vice President, Regulatory Counsel, Chief Compliance Officer.

As Millennium Laboratories General Counsel, Mr. Price will oversee all legal affairs of the company. Howard Appel, Millennium Laboratories' President, said, "We are very pleased to have someone of Martin's caliber join our senior leadership team.  Martin's depth of experience is a natural fit for our values-based culture and our leadership in national medication monitoring and corporate responsibility. We know he will make a tremendous contribution."

Prior to joining Millennium, Mr. Price was a Partner with the international law firm of Hogan Lovells US LLP, where he served as Millennium's outside counsel.  In addition to his work for Millennium, Mr. Price acted as lead counsel on behalf of several Fortune 500 corporations in defending class actions, government investigations, and prosecuting litigation against competitors.  His substantial healthcare expertise covers the full spectrum of federal and state compliance matters for clinical testing laboratories, including the federal Stark and anti-kickback laws, HIPAA, Hi-Tech and state rules and regulation. He holds a B.A. degree from the George Washington University and a M.A. degree from Duke University. He received his J.D. from the George Washington University Law School.

Martin Price commented, "I am excited to join Millennium as General Counsel. The company's outstanding reputation in the clinical laboratory industry is well-known and I am looking forward to an enhanced role with the organization as it continues its remarkable growth."

Price continued, "Janna Sipes brings a wealth of legal experience in life sciences, clinical laboratories, diagnostics and pharmaceuticals to Millennium.  Her regulatory and compliance expertise coupled with her sound business judgment will be a critical asset to our legal department and the company."

Before joining Millennium, Ms. Sipes served as Vice President, Legal and Human Resources, and Compliance Officer with Cypress Bioscience where she developed and oversaw all corporate compliance programs.  She held a similar position with Prometheus Laboratories, Inc., also in San Diego.  She holds a B.S. degree from Texas Tech University and earned her J.D. from Baylor University School of Law.

About Millennium Laboratories

Located in San Diego's life sciences cluster, Millennium Laboratories, Inc. is a national, research-based medication monitoring company whose test offering, technology, customer support, educational resources and experts are specifically focused on clinicians who treat chronic pain.  The company is recognized as a leader in pain management services, setting industry standards in drug testing and reporting, clinical research and education. Millennium serves as an industry educator and a compassionate advocate for pain sufferers throughout the United States. Millennium Laboratories is accredited by The Joint Commission, receiving the Gold Seal of Approval™ for healthcare quality and safety.

Among the numerous scientific and research achievements of the company's renowned laboratory team, Millennium Laboratories' reference laboratory is certified as a training facility for clinical toxicologist scientists and operates as a unique research component of the University of California, San Diego's (UCSD) doctoral program in Pharmacy.

As part of the company's commitment to pain management research and education, Millennium Laboratories established the Millennium Research Institute (MRI), a non-profit, national research center that conducts and disseminates original research focused on improving the experiences of people suffering from pain and pain-related disorders.  Millennium Research Institute maintains several national academic partnerships and supports collaborative research focused on greater understanding of the treatment of pain, improvements to patient safety and identification and prevention of prescription drug abuse.

For more information, visit the Millennium Laboratories website, www.becausepainmatters.com.


'/>"/>
SOURCE Millennium Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Surgicals Smart Instrument Purchasing Saves OR Personnel Time, Money
2. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur of the Year® San Diego Finalist
3. Zen Holding Corp. Signs LOI to Acquire Millennium Healthcare Solutions Inc.
4. Millennium Laboratories Launches New Educational Webinar Series for Pain Management Physicians
5. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego
6. Millennium Surgical adds "SurgicalInstruments.com" Name
7. Technology Embracing Pharmacy, Millennium Pharmacy Systems, Welcomes New CIO
8. Millennium Laboratories to Provide UnitedHealthcares Nationwide Network of Physicians Drug Monitoring and Pain Management Services
9. Pharmacy Industry Veteran Joins Millennium Pharmacy Systems as COO
10. Millennium Research Group to Release Their Latest US Clot Management Data
11. New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017 Tillotts Pharma is ... Berlin office was opened in January ... The portfolio includes Entocort ® for the treatment ... of ulcerative colitis, and VistaPrep ® for bowel ... specialty pharmaceutical company focused on the treatment of gastrointestinal ...
(Date:2/23/2017)... MabVax Therapeutics Holdings, Inc . ... announces that it has received notice from the ... initiation a Phase I clinical trial with MVT-1075 ... ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel fully ... the phase I clinical trial in patients with ...
(Date:2/23/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ( ... and dermatology biopharmaceutical company, today announced that it has ... as special advisers to the Company,s Board of ... board on financial and corporate strategy. Provectus ... of up to $2.5 million from Eric Wachter ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing LLC announces ... and explore the world from different perspectives. By providing a place for people ... understanding, increase empathy, and find greater happiness. , "Our approach to structuring ...
(Date:2/23/2017)... ... (PRWEB) ... opportunity for the nation to come together to combine its ... – with its favorite fruit – apples! To celebrate National ... to join the “Apple Madness” bracket tournament – a five-week, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Thomas Vas-Don ... and disciplined exercise regime, the author was able to successfully recover. In “ Origin ... relevant information for various sources on the principals of massage, anatomy , ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem ... recent years. The technology is so cutting edge, in fact, the U.S. Food ... stem cell procedures. However, successful patient outcomes in certain clinical stem cell procedures ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes customized ... room, fewer hospital admissions, and better blood pressure and glycemic control, a ... study can be found here . , The study comes as health ...
Breaking Medicine News(10 mins):